Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ketoconazole Contributes to Cryptorchidism Outcome Via Modulating Testicular Macrophage Trem2

NCT06560086 is registered in ClinicalTrials.gov with Affiliated Hospital of Nantong University as lead sponsor.

NCT NCT06560086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06560086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ketoconazole Contributes to Cryptorchidism Outcome Via Modulating Testicular Macrophage Trem2
Lead sponsor
Affiliated Hospital of Nantong University
Phase
Not applicable
Overall status
Unknown status
Start date
February 3, 2024
Completion date
December 31, 2024
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cryptorchidism